热门资讯> 正文
Galecto GAAP每股收益为-18.53美元，落后2.62美元
2025-03-20 04:52
- Galecto press release (NASDAQ:GLTO): FY GAAP EPS of -$18.53 misses by $2.62.
- Cash and cash equivalents as of December 31, 2024 were approximately $14.2 million. The Company anticipates that its cash and cash equivalents will be sufficient to fund operating expenses and capital requirements into 2026, including the submission of an investigational new drug application for GB3226 to the FDA. However, the Company will require substantial additional capital to finance its operations, including future clinical development of its GB3226 and GB1211 programs.
More on Galecto
- Seeking Alpha’s Quant Rating on Galecto
- Historical earnings data for Galecto
- Financial information for Galecto
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
